Conferences - Results from #8240

AUA 2018: Risk of Men with Intermediate Risk Prostate Cancer Going On To Definitive Treatment During Active Surveillance: Does a High PSA Predict a Worse Outcome? May 22, 2018

AUA 2018: Comparative Genomic Analysis of African American and Non-African American Prostate Cancers: A Report from the Decipher GRID Collaborative May 21, 2018

AUA 2018: Impact of Transient ADT with Leuprorelin 11.25 Mg on the Histological Progression of Indolent Prostate Cancer–Results of a Phase III Trial vs Active Surveillance May 21, 2018

AUA 2018: Analysis of Methylated DNA Markers for Prediction of Cancer Progression after Radical Prostatectomy May 21, 2018

AUA 2018: Four-year Follow-up of a Phase-3 Prospective Randomized Trial of Vascular-Targeted Phototherapy Versus Active Surveillance for Low-Risk Prostate Cancer May 21, 2018

AUA 2018: MRI-Guided Transurethral Ultrasound Ablation (TULSA) in Patients with Localized Prostate Cancer: Preliminary Results of TACT Pivotal Study May 21, 2018

AUA 2018: The “Metabolic” Overactive Bladder Syndrome May 21, 2018

AUA 2018: Validation of the Decipher Biopsy Test to Predict Adverse Pathology in Men Diagnosed with Low and Favorable Intermediate Risk Prostate Cancer May 21, 2018

AUA 2018: Wearable Fitness Trackers for Measurement of Behavioral Patterns Among Patients Undergoing Radical Cystectomy: A Pilot Study Assessing Feasibility and Utility May 21, 2018

AUA 2018: The Men’s Eating and Living (MEAL) Study: A Randomized Clinical Trial of a Diet Intervention in Men on Active Surveillance for Prostate Cancer May 21, 2018

AUA 2018: A Prospective Study to Evaluate Efficacy with the Nuro™ Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with Overactive Bladder Syndrome May 21, 2018

AUA 2018: Underactive Bladder: Evaluation and Management May 21, 2018

AUA 2018: OAB - Therapeutic Algorithm for Third-Line Therapies: When I Use What, and Why? May 21, 2018

AUA 2018: High Risk BCG Recurrent/Refractory Disease: Secondary Intravesical Therapy May 21, 2018

AUA 2018: Association Between Overactive Bladder Severity and Bold fMRI Brain Activity May 21, 2018

AUA 2018: Adherence to Bladder Cancer Guidelines and Issues with Implementation May 21, 2018

AUA 2018: Lumbosacral 1.5 Tesla MRI Compatibility with Sacral Neuromodulation May 21, 2018

AUA 2018: Prevalence of Nocturia in the Geriatric Populations May 21, 2018

AUA 2018: Extended First Uninterrupted Sleep Period (FUSP) in Nocturia Patients Following Treatment Desmopressin Using an Emulsified Microdose Formulation May 21, 2018

AUA 2018: Catheter Associated UTIs May 21, 2018

Page 413 of 616